Role of AP1 element in the activation of human eNOS promoter by lysophosphatidycholine

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 872-884

  Xing, Feiyue ^a,b   Jiang, Yong ^b   Liu, Jing ^a   Zhao, Kesen ^b   Mo, Yongyan ^b   Qin, Qinghe ^b   Wang, Jingzhen ^b   Ouyang, Jianming ^a   Zeng, Yaoying ^a  

^a JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Activator protein 1 element; Endothelial nitric oxide synthase; Lysophosphatidycholine; Regulation; Shear stress response element

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LYSOPHOSPHATIDYLCHOLINE; OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; QUANTITATIVE ANALYSIS; SHEAR STRESS; SHEAR STRESS RESPONSE ELEMENT;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MICE; MUTAGENESIS; MUTATION; NIH 3T3 CELLS; NITRIC OXIDE SYNTHASE TYPE III; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR AP-1;

EID: 33745598168     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20739     Document Type: Article

References (37)

1. Alexander C, Rietschel ET. 2001. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7:167-202.
2. Alikhani M, Alikhani Z, He HB, Liu RK, Popek BI, Graves DT. 2003. Lipopolysaccharides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts. J Biol Chem 278:52901-52908.
3. Anderson HDL, Rahmutula D, Gardner DG. 2004. Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 279:963-969.
4. 2 in T-lymphocyte activation: Implication in propagation of inflammatory reaction. Proc Natl Acad Sci USA 90:716-719.
5. Baird GS, Zacharias DA, Tsien RY. 2000. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA 97:11984-11989.
6. Bivalacqua TJ, Champion HC, Mehta YS, Abdel-Mageed AB, Sikka SC, Ignarro LJ, Kadowitz PJ, Hellstrom WJ. 2000. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 12:338-17.
7. Busses R, Fleming I. 1998. Pulsatile stretch and shear stress: Physical stimuli determining the production of endothelium derived relaxing factors. J Vasc Res 35:73-84.
8. Chicoine LG, Avitia JW, Deen C, Nelin LD, Earley S, Walker BR. 2002. Developmental differences in pulmonary eNOS expression in response to chronic hypoxia in the rat. J Appl Physiol. 93:311-318.
9. Cieslik K, Abrams CS, Wu KK. 2001. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase γ/Janus kinase 2/MEK-1-dependent pathway. J Biol Chem 276:1211-1219.
10. Cieslik K, Zembowicz A, Tang L, Wu KK. 1998. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273:14885-14890.
11. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A. 2003. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389-395.
12. Coulet F, Nadaud S, Agrapart M, Soubrier F. 2003. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278:46230-46240.
13. Engelmann B, Zieseniss S, Brand K, Page S, Lentschat A, Ulmer AJ, Gerlach E. 1999. Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. Arterioscler Thromb Vasc Biol 19:47-53.
14. Gan L, Selin-Sjogren L, Doroudi R, Jern S. 2000. Temporal regulation of endothelial ET-1 and eNOS expression in intact human conduit vessels exposed to different intraluminal pressure levels at physiological shear stress. Cardiovas Res 48:168-177.
15. Garcia-Parajo MF, Koopman M, van Dijk EM, Subramaniam V, van Hulst NF. 2001. The nature of fluorescence emission in the red fluorescent protein DsRed, revealed by single-molecule detection. Proc Natl Acad Sci USA 98:14392-14397.
16. Geller DA, Billia TR. 1998. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17:7-23.
17. German Z, Chambliss KL, Pace MC, Arnet UA, Lowenstein CJ, Shaul PW. 2000. Molecular basis of cell-specific endothelial nitric-oxide synthase expression in airway epithelium. J Biol Chem 275:8183-8189.
18. Hallemeesch MM, Janssen BJ, De Jonge WJ, Soeters PB, Lamers WH, Deutz NE. 2003. Increased iNOS-mediated and decreased cNOS-mediated NO production reflect blood pressure changes in LPS-challenged mice. Am J Physiol Endocrinol Metab 29:42002-42009.
19. Houston P, White BP, Campbell CJ, Braddock M. 1999. Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: Application for cardiovascular gene therapy. Human Gene Therapy 10:3031-3044.
20. Jones SP, Greer JJM, Haperen RV, Duncker DJ, Crom RD, Lefer DJ. 2003. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 100:4891-4896.
21. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, Marsden PA. 1999. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274:3076-3093.
22. Laumonnier Y, Nadaud S, Agrapart M, Soubrier F. 2000. Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem 275:40732-40741.
23. Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, Lukyanov SA. 1999. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol 17:969-973.
24. Morimoto M, Kume N, Miyamoto S, Ueno Y, Kataoka H, Minami M, Hayashida K, Hashimoto N, Kita T. 2001. Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells. Arteriosclerosis Thrombosis Vascular Biol 21:771-781.
25. 786 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870.
26. Parthasarathy S, Steinbreche UP, Barnett J, Witztum JL, Steinberg D. 1985. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82:3000-3004.
27. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC. 2003a. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930-937.
28. Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, Versari D, Sudanom I, Pessina AC, Salvetti A. 2003b. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 41:938-945.
29. Sato N, Kokame K, Miyata T, Kato H. 1998. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells. Thromb Haemos 79:217-221.
30. Saura M, Zaragoza C, Cao W, Bao C, Rodriguez-Puyol M, Rodriguez-Puyol D, Lowenstein CJ. 2002. Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ Res 91:806-813.
31. Traub O, Berk C. 1998. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Aterioscler Thromb Vasc Biol 18:677-685.
32. Tsao LT, Lee CY, Huang LJ, Kuo SC, Wang JP. 2002. Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO. Biochem Pharmacol 63:1961-1968.
33. Wedgwood S, Mitchell CJ, Fineman JR, Black SM. 2003. Developmental differences in the shear stress-induced expression of endothelial NO synthase: Changing role of AP-1. Am J Physiol Lung Cell Mol Physiol 284:L650-652.
34. Ye X, Liu SF. 2002. Lipopolysaccharide down-regulates promoter selective transcription factor 1(SP1) binding activity by promoting SP1 protein dephosphorylation and degradation. J Biol Chem 277:31863-31870.
35. Yoshimura M, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Nakamura ST, Mizuno Y, Harada E, Yasue H, Miyamoto Y, Saito Y, Kazuwa N. 2000. A T-7863C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. Am J Cardiol 85:710-714.
36. Zhang R, Min W, Sessa WC. 1995. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 270:15320-15326.
37. Ziegler T, Silacci P, Harrison VJ, Hayoz D. 1998. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32:351-355.